Complications of Infliximab Therapy in Children and Adolescents Affected by Crohn's Disease [12]

American Journal of Gastroenterology

Volumn 98, Issue 12, 2003, Pages 2812-2813

  Diamanti, Antonella ^a   Papadatou, Bronislava ^a   Knafelz, Daniela ^a   Gambarara, Manuela ^a   Ferretti, Francesca ^a   Castro, Massimo ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CORTISONE; INFLIXIMAB;

ADOLESCENT; ANAPHYLAXIS; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DRUG SAFETY; DYSPHAGIA; DYSPNEA; FACE EDEMA; FLUSHING; HUMAN; HYPOTENSION; IMMUNOTHERAPY; LETTER; OXYGEN THERAPY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; TACHYCARDIA; THORAX PAIN; URTICARIA;

EID: 0347364697     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.08757.x     Document Type: Letter

References (2)

1. Stephens MC, Shepanski MA, Mamula P, et al. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol 2003;98:104-11.
2. Hyams JS. Infliximab treatment of Crohn's disease in children: It's time to not go retro(spective). Am J Gastroenterol 2003;98:5-6.